EU approval boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy: GlobalData Read more
AbbVie’s Rinvoq for Crohn’s Disease to see rapid uptake by healthcare providers: GlobalData Read more
China poised to lead the way with world’s first oral insulin for type 2 diabetes: GlobalData Read more
Termination of Ultragenyx’s UX053 Phase I/II study is a minor setback for mRNA therapeutics: GlobalData Read more